Clinical Trials Browser

Phase 1/2 × Unknown × oregovomab × Clear all

NCT04938583 2023-10-17

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Phase 1/2 Unknown

Ovarian Neoplasms

NCT04620954 2021-12-01

ORION-02

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial